La testimonianza di Gianpiero (membro del direttivo A.I.NET) su Repubblica
Dal sito di Repubblica una importante testimonianza sulla convivenza con un tumore neuroendocrino di uno dei componenti del comitato direttivo A.I. NET (i dati epidemiologici dell’introduzione dell’articolo sono un po sottostimati ma la sostanza importante e’ la testimonianza).
Lavori piu’ significativi realizzati con il contributo dell’Associazione
Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids
Ferolla P, Daddi N, Urbani M, Semeraro A, Ribacchi R, Giovenali P, Ascani S, De Angelis V, Crinò L, Puma F, Daddi G; Regional Multidisciplinary Group for the Diagnosis and Treatment of Neuroendocrine Tumors, CRO, Umbria Region Cancer Network, Italy.
J Thorac Oncol. 2009 Mar;4(3):383-7
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Faggiano A, Grimaldi F, Pezzullo L, Chiofalo MG, Caracò C, Mozzillo N, Angeletti G, Santeusanio F, Lombardi G, Colao A, Avenia N, Ferolla P.
Endocr Relat Cancer. 2009 Mar;16(1):225-31. Epub 2008 Nov 12.
Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours.
Clin Endocrinol (Oxf). 2007 Jan;66(1):1-6.
Clinical characterization of familial isolated pituitary adenomas.
J Clin Endocrinol Metab. 2006 Sep;91(9):3316-23. Epub 2006 Jun 20.
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.
J Clin Endocrinol Metab. 2005 May;90(5):2603-9. Epub 2005 Feb 15.
Articolo scaricabile gratuitamente ciccando sul seguente link:
http://jcem.endojournals.org/cgi/content/full/90/5/2603
Daddi N, Ferolla P, Urbani M, Semeraro A, Avenia N, Ribacchi R, Puma F, Daddi G.
Surgical treatment of neuroendocrine tumors of the lung.
Eur J Cardiothorac Surg. 2004 Oct;26(4):813-7.
P. Ferolla, G. Scarpelli, C. Giammartino; G. Angeletti, F. Santeusanio
Analoghi della Somatostatina nei Tumori Neuroendocrini gastro-entero-pancreatici e toracici, Journal of Endocrinological Investigation, Vol 28 Suppl 6, 2005
Prevalence of the neuroendocrine phenotype in thymus neoplasms
Chir Ital. 2002 May-Jun;54(3):351-4. Italian.
P. Ferolla, AG Faggiano, G. Angeletti; F. Santeusanio; G. Lombardi; A. Colao:
“La caratterizzazione biologica dei NET: ruolo diagnostico e prognostico dei marcatori Neuroendocrini”,
L’Endocrinologo, Giugno 2006
Adrian F. Daly, Jean-François Vanbellinghen, Sok Kean Khoo, Marie-Lise Jaffrain-Rea,
Luciana A. Naves, Mirtha A. Guitelman, Arnaud Murat, Philippe Emy, Anne-Paule
Gimenez-Roqueplo, Guido Tamburrano, Gérald Raverot, Anne Barlier, Wouter De
Herder, Alfred Penfornis, Enrica Ciccarelli, Bruno Estour, Pierre Lecomte, Blandine
Gatta, Olivier Chabre, María Isabel Sabaté, Xavier Bertagna, Natalia Garcia Basavilbaso,
Graciela Stalldecker, Annamaria Colao, Piero Ferolla, Jean-Louis Wémeau, Philippe
Caron, Jean-Louis Sadoul, Adriana Oneto, Françoise Archambeaud, Alain Calender,
Olga Sinilnikova, Carmen Fajardo Montañana, Francesco Cavagnini, Vaclav Hana,
Angela Solano, Dreanina Delettieres, Douglas C. Luccio-Camelo, Armando Basso,
Vincent Rohmer, Thierry Brue, Vincent Bours, Bin Tean Teh, and Albert Beckers.
Aryl Hydrocarbon Receptor Interacting Protein Gene Mutations in Familial Isolated
Pituitary Adenomas: Analysis in 73 Families.
J Clin Endocrin Metab. First published ahead of print January 23, 2007 as doi:10.1210/jc.2006-2513
Piero Ferolla, Gabriella Angeletti, Fausto Santeusanio
Medical Treatment Of Well Differentiated Neuroendocrine Tumors;
Journal of Supportive and Palliative Cancer Care, June n2006
Altri lavori realizzati con il contributo dell’associazione:
Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007.
J Thorac Oncol. 2008 Oct;3(10):1194-201.
PMID: 18827620 [PubMed – in process]
Daddi N, Urbani M, Semeraro A, Capozzi R, Scarpelli G, Avenia N, Puma F, Ferolla P, Ribacchi R, Daddi G.
[Surgical treatment of well differentiated neuroendocrine tumours of the lung]
G Chir. 2008 May;29(5):246-9. Italian.
PMID: 18507963 [PubMed – indexed for MEDLINE]
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers.
J Endocrinol Invest. 2008 Mar;31(3):277-86. Review.
PMID: 18401212 [PubMed – indexed for MEDLINE]
Faggiano A, Mansueto G, Ferolla P, Milone F, del Basso de Caro ML, Lombardi G, Colao A, De Rosa G.
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors.
J Endocrinol Invest. 2008 Mar;31(3):216-23.
PMID: 18401203 [PubMed – indexed for MEDLINE]
Abstract e Presentazionia Congressi:
Pagina In costruzione/under construction
Altri articoli di interesse:
Guidelines for diagnosis and therapy of MEN type 1 and type 2.
J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71.
Articolo scaricabile gratuitamente ciccando sul seguente link:
http://jcem.endojournals.org/cgi/content/full/86/12/5658
Libri
I Tumori Neuroendocrini
Manuale di trattamento diagnostico e terapeutico
I Tumori Neuroendocrini – Manuale di trattamento diagnostico e terapeutico. Seconda edizione, edito in 2500 copie, a cura di Lodovico Rosato, coordinatori scientifici Piero Ferolla – Nicola Avenia – Annamaria Colao. Grafica Santhiatese Editrice, 2007 (ISBN 978-88-87374-82-7).